Evidence supporting the use of: Fucoidan
For the health condition: Hepatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Fucoidan is a sulfated polysaccharide found mainly in various species of brown seaweed. Its use for hepatitis is supported by a growing body of preclinical scientific evidence, though high-quality human clinical trials are still limited. Laboratory studies have demonstrated that fucoidan exhibits a range of bioactivities, including antiviral, anti-inflammatory, and immunomodulatory effects. Specifically, in vitro and animal research has shown that fucoidan can inhibit hepatitis B virus (HBV) replication and reduce liver inflammation by modulating immune responses and blocking viral entry into hepatocytes. Some studies have also reported protective effects against liver fibrosis and oxidative stress, which are key features of chronic hepatitis progression.

However, the majority of evidence stems from animal models and cell culture studies, with only a few small-scale human studies or clinical trials published to date. These preliminary human data suggest potential benefits, such as improved liver enzyme profiles and reduced hepatic inflammation, but are not yet robust enough to confirm efficacy or safety for widespread clinical use.

In summary, while there is promising scientific rationale and early-stage data supporting fucoidan's potential for hepatitis management, the current level of evidence rates as 2 out of 5 due to the lack of large-scale, well-controlled human trials. More research is needed before fucoidan can be considered a validated therapeutic option for hepatitis.

More about Fucoidan
More about Hepatitis

Products containing Fucoidan

We currently have no products on Vitabase that contain this ingredient.